Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2094 (Published 03 June 2020) Cite this as: BMJ 2020;369:m2094Linked Editorial
Pediatric inflammatory syndrome temporally related to covid-19
Read our latest coverage of the coronavirus pandemic
All rapid responses
Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles or when it is brought to our attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not including references and author details. We will no longer post responses that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Dear Editor,
Toubiana et al investigated a cluster of 21 children with features of Kawasaki disease admitted to a regional reference center in Paris between April and May 2020.(1) The authors propose that their study objective is to describe the population and to report on the temporal association of SARS-CoV-2 infection with the paediatric inflammatory multisystem syndrome. A major focus of the authors, however, is the ethnicity of the cases, positioned as an etiologic factor of the pathophysiology of the syndrome, a predictor for the evolution of the pandemic and a basis to inform policy making. Twelve (57%) of the cases are reported to have at least one parent born in sub-Saharan Africa or the Caribbean.
While surveillance of racial disparities is an important public health function, the careless use of ethnicity or race in etiologic research is dangerous, whether in relation to infection and disease in the context of the COVID-19 pandemic, or in biomedical research generally.(2) At a time when our understanding of the risk factors for SARS-CoV-2 transmission, infection and disease all remain limited, these crude observations are prone to misinterpretation.
Firstly, the observations in Toubiana et al are based on those tested for SARS-CoV-2 and confirmed as COVID-19 cases. This group is highly selected from the infected population based on symptom presentation, as well as on innumerable barriers of access including language, neighborhood, socioeconomic and demographic factors. Investigation of risk factors for infection and disease among a selected and unrepresentative subgroup of the population leads to distorted inferences.(3) While we are rather confident that all the children with the inflammatory syndrome are counted, the denominator of children at risk having been infected with SARS-CoV-2 is unknown.
In both France and the UK, and even more widely discussed in the US, exposure to SARS-CoV-2 infection and COVID-19 disease disproportionally affect people of color, a pattern that is clearly understandable in terms of socio-economic differences and inequalities in occupation and housing.(4) Given that exposure and infection by SARS-CoV-2 are dependent on race and ethnicity for social reasons, even if the incidence of the inflammatory syndrome is randomly distributed and independent of race, one would still observe an overrepresentation of ethnic minority children with the syndrome. This observation alone is therefore no evidence of increased severity of COVID-19 in children by ethnicity.
Toubiana et al offer two explanations for greater susceptibility of these children for the syndrome: social environment and genetics. Some crude markers for socio-economic status were collected by the authors (residence in “unhealthy” or subsidized housing), but these measures are quite limited and once again, there is no information on the socio-economic characteristics of all infected children, only the ascertained cases. As long as there is no representative testing data to reflect the prevalence of exposed and infected cases by ethnicity, the association between these variables in the dataset cannot provide valid evidence regarding the reliable markers for developing the inflammatory syndrome nor the underlying etiology of the disease.(5)
The second proffered explanation, ethnicity as a proxy for genetic differences, will doubtlessly be explored aggressively. To successfully explore this hypothesis, one must collect and analyze the genotypes of cases and a representative sample of non-cases, but ethnicity is a misleading distraction in this endeavor. The facile connection of race and ethnicity to genetics reveals a common misunderstanding, but it will not solve this medical mystery, nor has it solved any in the past.(6) The recurrent misguided use of race or ethnicity as a facile proxy for genetic predisposition rests on the long-outdated presumption that these social categories mark important genetic differences.(7) With the human genome now mapped, it is abundantly clear that almost all human genetic variation occurs within racial groups, not between them.(8)
A plethora of conflicting definitions are applied to ethnicity in medical studies.(9) Toubiana et al. define ethnicity based on the country of birth of one of the parents, a definition that is obviously prone to misclassification with respect to both identity and biological ancestry.(10) This measure clearly corresponds more to recent immigration than it does to any biological information. It is a practical definition for these authors because the French have opted to forbid the collection of racialized data for official purposes, exactly to avoid this kind of biological myth-making.(11) So the authors are left categorizing paediatric cases in terms of social history, specifically being children of recent immigrants from certain regions, and should therefore likewise interpret the variable as such.
No matter which arbitrary definition is used for race, however, research consistently shows that while genetic differences between human beings do exist, broad phenotypical groupings like “black” and “white”, or vast continental agglomerations like “Africans” are terrible proxies for these differences.(12) Moreover, now that DNA is routinely extracted and patients can be inexpensively genotyped, it is a proxy that is completely irrelevant, because if you want to know something about genetics, you measure genes. There is no longer any excuse for 19th century proxies based on quaint myths and outdated stereotypes.
Race and ethnicity are social constructs and the collection and reporting of these variables need to be understood within a perspective of social epidemiology and not misinterpreted as biological constructs.(2) The current pandemic, more than being a puzzle only for virologists, immunologists and rheumatologists, is also fundamentally a social and political phenomenon. Diseases happen to individuals, but epidemics happen to whole societies. Hence the critical determining role of social factors such as nativity, occupation and race in shaping its evolution and providing the context for every observation and potential intervention.
The authors’ conclusion to call children living in the African continent a high risk population for this rare complication based on this study is therefore completely misguided. Even worse, the primary action recommended is that African countries should prepare with a sufficient supply of immunoglobulins. A continued and even strengthened immunization program as well as improvements in the quality and access to basic health care would undoubtedly contribute much more to the health of children worldwide through this pandemic.
1) Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S, Frange P. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020 Jun 3;369.
2) Cooper RS, Nadkarni GN, Ogedegbe G. Race, ancestry, and reporting in medical journals. JAMA 2018;320:1531-2.
3) Griffith G, Morris TT, Tudball M, Herbert A, Mancano G, Pike L, Sharp GC, Palmer TM, Smith GD, Tilling K, Zuccolo L. Collider bias undermines our understanding of COVID-19 disease risk and severity. medRxiv. 2020
4) Kirby T. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities. The Lancet Respiratory Medicine. 2020 May 8
5) Kaufman JS, Cooper RS. Seeking causal explanations in social epidemiology. American journal of epidemiology. 1999 Jul 15;150(2):113-20.
6) Saini A. Stereotype threat. The Lancet. 2020 May 23;395(10237):1604-5.
7) Barr DA. The practitioner's dilemma: Can we use a patient's race to predict genetics, ancestry, and the expected outcomes of treatment?. Annals of Internal Medicine. 2005 Dec 6;143(11):809-15.
8) Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA, Feldman MW. Genetic structure of human populations. science. 2002 Dec 20;298(5602):2381-5.
9) Bokor-Billmann T, Langan EA, Billmann F. The reporting of race and/or ethnicity in the medical literature: a retrospective bibliometric analysis confirmed room for improvement. Journal of clinical epidemiology. 2020 Mar 1;119:1-6.
10) Stronks K, Kulu-Glasgow I, Agyemang C. The utility of ‘country of birth’for the classification of ethnic groups in health research: the Dutch experience. Ethnicity & health. 2009 Jun 1;14(3):255-69.
11) Simon P. The choice of ignorance: The debate on ethnic and racial statistics in France. In Social Statistics and ethnic diversity 2015 (pp. 65-87). Springer, Cham
12) Cooper RS, Kaufman JS, Ward R. Race and genomics. N Engl J Med. 2003;348(12):1166‐1170. doi:10.1056/NEJMsb022863
Competing interests: Joanna Merckx is employed by bioMérieux Canada as Director of Medical Affairs bioMérieux Canada, Inc. The opinions she expresses are her own.
Dear Editor
I was looking at the the treatment plan
All 21 patients received high dose intravenous immunoglobulin (2 g/kg) after fever for a median duration of 5 (range 0-12) days and low dose aspirin (3-5 mg/kg/day
I was thinking it might be better to give COVID19 plasma therapy since it would contain immunoglobulin to COVID19 maybe a trial ?
Competing interests: No competing interests
Does preexisting endothelial dysfunction play a role in multisystem inflammatory syndrome in children with a presentation similar to Kawasaki disease shock syndrome
Dear Editor
After reading the interesting prospective observational study of Toubiana et al. (1) two questions arise. The first one is about the high number of patients of African ancestry. To date, it is accepted that COVID-19 can result in a significant disease burden in children, many with significant comorbidities, but it is confirmed that severe illness is less frequent, and early hospital outcomes in children are better than in adults (2). Nevertheless, a multisystem inflammatory syndrome in children with a presentation similar to Kawasaki disease shock syndrome can occur and has been observed in several countries (3-6). Toubiana ed al reported an outbreak of Kawasaki-like multisystem inflammatory syndrome among children and adolescents in the Paris area that might be related to SARS-CoV-2 (1). They observed that 57 % of patients were of African ancestry. In adults, recent CDC data suggest an overrepresentation of people of color among hospitalized patients (7). “Pre-existing” endothelial dysfunction has been suggested as a unifying hypothesis for the burden of severe SARS-CoV-2 (8). Endothelial dysfunction is silently present in children and young adults exposed to conventional risk factors including hypercholesterolemia or family history of hypertension. Indeed, conventional risk factors “cluster” in certain individuals, and clear relations emerge between the risk factor “burden” and the degree of endothelial dysfunction. This has particular relevance for the rapidly expanding population of overweight and obese children with mild hypertension, dyslipidemia, insulin resistance, and low-grade inflammation (9). Furthermore, decreased endothelial function has been demonstrated in African-American adolescents (10) and we postulate it might play a role in the high numbers of children of African ancestry with the multisystem inflammatory syndrome in this study.
The second question arises with the presence of gastrointestinal symptoms during the early stage of illness in 100 % of patients. The possibility of the gastrointestinal system as a potential first route of SARS-CoV-2 invasion and transmission has been postulated and can explain gastrointestinal symptoms during the early stage of COVID-19 in all children (11).
Finally, it would be very interesting to evaluate the presence and degree of endothelial dysfunction in the group of the children studied by Toubiana that have been affected by the hyperinflammatory syndrome with multiorgan involvement similar to Kawasaki disease shock syndrome. Moreover, in the case of COVID-19 patients with early gastrointestinal symptoms, negative rectal swab for SARS-CoV-2 should be obtained to consider them not contagious and in terms of containment of the disease, they should be kept in isolation as long as signs of viral RNA shedding are shown.
References
1) Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, et al. Kawasaki-like multisystem inflammatory syndrome in children during the COVID-19 pandemic in Paris, France: a prospective observational study. BMJ 2020;369:m2094. https://www.bmj.com/content/369/bmj.m2094
2) Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. Published online May 11, 2020. DOI:10.1001/jamapediatrics.2020.1948
3) Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, and Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607-8. DOI:10.1016/S0140-6736(20)31094-1.
4) Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020. DOI:10.1016/S0140-6736(20)31103-X.
5) Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr 2020. DOI: 10.1542/hpeds.2020-0123. 6) Dufort EM, Koumans EH, Chow EJ. Rosenthal EM, Muse A, et al. Multisystem Inflammatory Syndrome in Children in New York State. NEJM. June 29, 2020. DOI: 10.1056/NEJMoa2021756.
7) CDC. COVID-19 in Racial and Ethnic Minority Groups. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/racial-.... Accessed 5 June 2020.
8) Ghirga G. R.R. Pre-existing endothelial dysfunction: a unifying hypothesis for the burden of severe SARS-CoV-2. BMJ 2020;368:m627.
https://www.bmj.com/content/369/bmj.m1794/rr-1
9) Childhood origins of endothelial dysfunction. Heart. 2005 Oct; 91(10): 1272–1274. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769127/
10) Mary M. Duck MM, and Hoffman RP. Impaired Endothelial Function in Healthy African-American Adolescents Compared to Caucasians. J Pediatr. 2007 Apr; 150(4): 400–406. DOI: 10.1016/j.jpeds.2006.12.034
11) Ghirga G. R.R. SARS-COV-2 lung infection could be acquired upon exposure to the virus through the gastrointestinal tract, one important missing piece. BMJ 2020;368:m627. https://www.bmj.com/content/368/bmj.m627/rr-32.
12) Barth RE, De Regt MJA. Persistence of viral RNA in stool samples from patients recovering from COVID-19. BMJ 2020;369:m1724. DOI: https://doi.org/10.1136/bmj.m1724
Competing interests: No competing interests